Docusign Inc. (NASDAQ:DOCU - Get Free Report) Director Anna Marrs sold 363 shares of the stock in a transaction that occurred on Thursday, March 5th. The shares were sold at an average price of $46.33, for a total value of $16,817.79. Following the transaction, the director owned 12,251 shares in the company, valued at $567,588.83. This trade represents a 2.88% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.
Anna Marrs also recently made the following trade(s):
- On Friday, December 5th, Anna Marrs sold 363 shares of Docusign stock. The shares were sold at an average price of $64.50, for a total transaction of $23,413.50.
Docusign Price Performance
DOCU stock traded up $2.01 during trading on Thursday, hitting $48.23. The stock had a trading volume of 4,751,965 shares, compared to its average volume of 4,920,508. The company's 50-day moving average price is $54.26 and its two-hundred day moving average price is $66.00. Docusign Inc. has a twelve month low of $40.16 and a twelve month high of $94.67. The stock has a market capitalization of $9.66 billion, a P/E ratio of 33.73, a PEG ratio of 2.03 and a beta of 1.03.
Analysts Set New Price Targets
DOCU has been the topic of a number of analyst reports. JPMorgan Chase & Co. reduced their price objective on Docusign from $80.00 to $78.00 and set a "neutral" rating on the stock in a research report on Friday, December 5th. Bank of America dropped their price objective on shares of Docusign from $102.00 to $82.00 and set a "neutral" rating for the company in a report on Friday, December 5th. Zacks Research cut shares of Docusign from a "strong-buy" rating to a "hold" rating in a research report on Monday, November 24th. Wells Fargo & Company cut their price target on shares of Docusign from $85.00 to $75.00 and set an "equal weight" rating for the company in a report on Friday, December 5th. Finally, Piper Sandler reduced their price target on shares of Docusign from $90.00 to $75.00 and set a "neutral" rating on the stock in a research report on Friday, December 5th. Five analysts have rated the stock with a Buy rating and sixteen have assigned a Hold rating to the company's stock. Based on data from MarketBeat, the stock presently has an average rating of "Hold" and a consensus price target of $78.80.
Read Our Latest Stock Analysis on Docusign
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Central Pacific Bank Trust Division acquired a new position in shares of Docusign during the fourth quarter worth $25,000. Modus Advisors LLC acquired a new position in shares of Docusign during the 4th quarter worth about $27,000. Torren Management LLC purchased a new position in shares of Docusign in the 4th quarter valued at about $28,000. Aventura Private Wealth LLC purchased a new position in shares of Docusign in the 4th quarter valued at about $30,000. Finally, True Wealth Design LLC raised its position in shares of Docusign by 105.2% during the 4th quarter. True Wealth Design LLC now owns 433 shares of the company's stock worth $30,000 after acquiring an additional 222 shares in the last quarter. Institutional investors and hedge funds own 77.64% of the company's stock.
About Docusign
(
Get Free Report)
DocuSign, Inc NASDAQ: DOCU is a leading provider of electronic signature and digital transaction management solutions. The company's flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign's Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.
DocuSign's platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Docusign, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Docusign wasn't on the list.
While Docusign currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Click the link to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.